Moyamoya Disease-Standards and Advances in Revascularization Procedure and Peri-operative Management

Miki Fujimura1

  • 1Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan. fujimur@med.hokudai.ac.jp.

Insights

Superficial temporal artery-middle cerebral artery (STA-MCA) bypass surgery improves cerebral blood flow in Moyamoya disease (MMD) patients. Understanding peri-operative hemodynamics is crucial for managing post-surgical complications like hyperperfusion and ischemia.

Area of Science:

  • Neurosurgery
  • Cerebrovascular Medicine
  • Hemodynamics

Background:

  • Moyamoya disease (MMD) is a chronic occlusive cerebrovascular condition.
  • It involves progressive stenosis of the internal carotid artery and abnormal basal brain vasculature.
  • STA-MCA bypass is a key surgical intervention for MMD.

Purpose of the Study:

  • To demonstrate the standard STA-MCA bypass procedure for adult MMD patients.
  • To highlight potential pitfalls in the early postoperative period.
  • To describe characteristic peri-operative hemodynamic changes post-surgery.

Main Methods:

  • Detailed description of the standard STA-MCA bypass with indirect pial synangiosis.
  • Analysis of peri-operative hemodynamic conditions in adult MMD patients.
  • Identification of complications such as local cerebral hyperperfusion and watershed shift phenomenon.

Main Results:

  • STA-MCA bypass is a preferred procedure for improving cerebral blood flow in MMD.
  • Flow-augmentation bypass may prevent re-bleeding in hemorrhagic MMD.
  • Post-surgery, patients may experience local cerebral hyperperfusion and hemodynamic ischemia due to watershed shift.

Conclusions:

  • Thorough understanding of MMD pathology and peri-operative hemodynamics is essential for surgical success.
  • Awareness of potential complications like hyperperfusion and ischemia is critical for managing adult MMD patients undergoing bypass surgery.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
45
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
34
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
56
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
58
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
45
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
61